fbpx

This MS drug increases risk of hospitalisation

This MS drug increases risk of hospitalisation Published: 27 August 2021 A new study has found that Ocrevus (ocrelizumab) slows disability progression and reduces relapse risk in people with multiple sclerosis (MS) but is also associated with higher hospitalisation risk in older people.  Most of the hospitalisations were from urinary
Read More

Ocrevus may remove chicken pox immunity

Ocrevus may remove chicken pox immunity Published: 25 August 2020 The multiple sclerosis (MS) drug Ocrevus (ocrelizumab) may interfere with chicken pox immunity acquired from a vaccine, according to a new case study from Italy.  Ocrevus suppresses the immune system’s attacks on the myelin sheath. It targets mature B-cells and
Read More